Beneficial effect of oclacitinib in a case of feline pemphigus foliaceus
Isaac Carrasco, Marta García‐Legaz Martínez, Gloria Albinyana
Abstract
Pemphigus foliaceous (PF) is a pustular, immune-mediated skin disease characterised by acantholytic cells and commonly treated with high doses of glucocorticoids. This report describes one case of feline PF successfully controlled using oral oclacitinib, suggesting a possible therapeutic alternative to glucocorticoids in some cases.
Topics & Concepts
Pemphigus foliaceusPemphigusMedicineDermatologyPemphigus vulgarisDesmoglein 1ImmunologyDiseaseAutoimmune diseasePathologyAutoantibodyAntibodyAutoimmune Bullous Skin DiseasesCoagulation, Bradykinin, Polyphosphates, and AngioedemaHair Growth and Disorders